Agilon Health (NYSE:AGL) Stock Price Up 10.3% – Should You Buy?

Agilon Health, Inc. (NYSE:AGL)’s stock price rose 10.3% during trading on Monday . The stock traded as high as $89.62 and last traded at $90.18. Approximately 226,104 shares traded hands during mid-day trading, a decline of 39% from the average daily volume of 368,133 shares. The stock had previously closed at $81.73.

Analyst Ratings Changes

AGL has been the subject of several research analyst reports. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Jefferies Financial Group raised shares of Agilon Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $27.50 to $48.00 in a research report on Thursday, May 7th. Citigroup reaffirmed a “neutral” rating and issued a $80.00 target price (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th. Benchmark raised their target price on shares of Agilon Health to $13.00 and gave the stock a “buy” rating in a research report on Thursday, April 2nd. Finally, Weiss Ratings raised shares of Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 12th. Five investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $45.05.

Agilon Health Price Performance

The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The firm’s fifty day moving average price is $28.18 and its two-hundred day moving average price is $21.07. The stock has a market capitalization of $1.35 billion, a PE ratio of -3.75 and a beta of 2.29.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. On average, equities analysts predict that Agilon Health, Inc. will post -4.17 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Wealthcare Advisory Partners LLC purchased a new position in shares of Agilon Health during the third quarter valued at approximately $26,000. CIBC Bancorp USA Inc. purchased a new stake in Agilon Health during the third quarter valued at approximately $34,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in Agilon Health during the third quarter valued at approximately $37,000. Tower Research Capital LLC TRC increased its holdings in Agilon Health by 214.0% during the second quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock valued at $85,000 after buying an additional 25,270 shares during the last quarter. Finally, Independent Advisor Alliance purchased a new stake in Agilon Health during the third quarter valued at approximately $39,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.